XML 42 R30.htm IDEA: XBRL DOCUMENT

Equity Award Plans (Tables)

6 Months Ended

Jun. 30, 2018

Table Text Blocks

Schedule of Restricted Stock Unit ("RSU") activity


				Weighted‑			Weighted‑
				Average			Average Remaining		Aggregate
		Number of		Grant Date Fair			Contractual Term		Intrinsic
		Shares		Value Per Share			(in years)		Value
Outstanding at December 31, 2017		—		$	—		—		$	—
Granted		412,521			8.22
Vested		—
Forfeited		—
Outstanding at June 30, 2018		412,521					1.58		$	10,726
RSUs vested and expected to vest at June 30, 2018		368,419					1.50		$	9,579
RSUs vested and exercisable at June 30, 2018		—								—

Schedule of stock-based compensation expense


		Three Months Ended June 30,						Six Months Ended June 30,
		2018			2017			2018			2017
Cost of subscription, license and support revenue		$	137		$	85		$	273		$	160
Cost of services revenue			73			57			130			111
Sales and marketing expense			1,228			744			2,164			1,617
Research and development expense			894			651			1,458			1,270
General and administrative expense			1,155			623			1,851			1,209
		$	3,487		$	2,160		$	5,876		$	4,367

Series A convertible preferred stock

Table Text Blocks

Schedule of stock option activity


							Weighted-
				Weighted-			Average Remaining			Aggregate
		Number of		Average			Contractual Term			Intrinsic
		Shares		Exercise Price			(in years)			Value
Outstanding at December 31, 2017		4,689,576		$	0.98		5.18		$	10,539
Granted		195,312			3.60
Exercised		(360,385)			0.59
Forfeited		(351,562)			0.52
Converted to common stock options upon IPO		(4,172,941)			1.18
Outstanding at June 30, 2018		—

Schedule of stock option assumptions


		Six Months Ended June 30,
		2018			2017
Risk-free interest rate		2.74	%		2.17	%
Expected term (in years)		6.25			6.25
Expected volatility		43.85	%		47.42	%
Expected dividend yield		—	%		—	%

Table Text Blocks

Schedule of stock option activity


							Weighted-
				Weighted-			Average Remaining		Aggregate
		Number of		Average			Contractual Term		Intrinsic
		Shares		Exercise Price			(in years)		Value
Outstanding at December 31, 2017		14,183,221		$	4.89		7.16		$	17,626
Granted		2,905,375			12.28
Exercised		(624,019)			4.04
Forfeited		(543,216)			6.18
Series A options converted to common stock options upon IPO		1,693,197			2.90
Series E-1 options converted to common stock options upon IPO		837,835			0.86
Outstanding at June 30, 2018		18,452,393		$	5.68		7.03		$	375,031
Vested and expected to vest at June 30, 2018		17,748,554		$	5.54		6.95		$	363,193
Options exercisable at June 30, 2018		10,612,656		$	3.81		5.71		$	235,524

Schedule of stock option assumptions


		Six Months Ended June 30,
		2018			2017
Risk-free interest rate		2.74-2.98	%		2-2.17	%
Expected term (in years)		6.25			6.25
Expected volatility		43.62-43.85	%		46.72-47.42	%
Expected dividend yield		—	%		—	%